Pharmaceutical preparation
AssigneeAlgeta ASA
InventorThomas RAMDAHL
Life of this patent
Estimating the term…
Abstract
A pharmaceutical preparation comprising at least one complexed alpha-emitting radionuclide and at least one polysaccharide biopolymer.
Claims27
A pharmaceutical preparation comprising at least one complexed alpha-emitting radionuclide and at least one polysaccharide biopolymer.
A method for generating an injectable solution of at least one complexed alpha-emitting radionuclide, said method comprising contacting a pharmaceutical preparation of said least one complexed alpha-emitting radionuclide with at least one polysaccharide biopolymer and subsequently separating said solution of at least one complexed alpha-emitting radionuclide from said at least one polysaccharide biopolymer.
A method for the removal of at least one uncomplexed radionuclide from a pharmaceutical preparation comprising a solution of at least one complexed alpha-emitting radionuclide, said method comprising contacting said pharmaceutical preparation with at least one polysaccharide biopolymer.
The use of at least one polysaccharide biopolymer for the removal of at least one uncomplexed radionuclide from a pharmaceutical preparation comprising a solution of at least one complexed alpha-emitting radionuclide.
A kit for the preparation of an injectable solution, said kit comprising least one polysaccharide biopolymer and at least one solution of a complexed alpha-emitting radionuclide.
Dependencies are inferred from the claim text.